DRUG-METABOLIZING-ENZYMES IN THE RAT PITUITARY-GLAND

被引:0
|
作者
GHERSIEGEA, JF
LEININGERMULLER, B
MINN, A
SIEST, G
机构
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain protection against chemicals is mainly provided by the specific properties of cerebral microvessels forming the blood-brain barrier. In addition, several drug metabolizing enzymes have been evidenced both in brain tissue and in cerebral capillaries, suggesting their participation in the enzymatic protection of this organ. The pituitary gland, like true circumventricular organs, lacks a tight vascular endothelium and therefore is especially sensitive to blood-native toxic or pharmacologically active molecules. We report here the presence of cytochrome P-450 in the pituitary gland and its main mitochondrial localization. The O-dealkylase activity measured towards 7-benzoxyresorufin, a substrate for the main cytochrome P-450 isoforms involved in the metabolism of xenobiotics, was 5 times higher in the pituitary gland than in the brain cortex. Similarly, microsomal epoxide hydrolase, which inactivates reactive epoxides to trans diol molecules, and two conjugating enzymes, 1-naphthol UDP-glucuronosyltransferase and glutahione-S-transferase, display respectively 6, 4 and 7 times higher activities in the pituitary gland. 7-Benzoxyresorufin-O-dealkylase, 1-naphthol UDP-glucuronosyltransferase and membrane-bound epoxide hydrolase activities were significantly increased in the pituitary gland as an adaptive response to an in vivo treatment by an exogenous inducer, 3-methylcholanthrene. These results suggest that these enzymatic systems play a role in the protection of the pituitary gland towards drugs or toxic substances.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 50 条
  • [31] INHIBITION OF DRUG-METABOLIZING-ENZYMES IN RAT AFTER BCG TREATMENT
    FARQUHAR, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 128 - 128
  • [32] DRUG-METABOLIZING-ENZYMES AS EVOLUTIONARY PROBES
    JONDORF, WR
    DRUG METABOLISM REVIEWS, 1981, 12 (02) : 379 - 430
  • [33] THE DISCOVERY OF THE MICROSOMAL DRUG-METABOLIZING-ENZYMES
    AXELROD, J
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (10) : 383 - 386
  • [34] MULTIPLICITY OF LIVER DRUG-METABOLIZING-ENZYMES
    LU, AYH
    DRUG METABOLISM REVIEWS, 1979, 10 (02) : 187 - 208
  • [35] INDUCIBILITY OF DRUG-METABOLIZING-ENZYMES IN THE SKIN
    RUZICKA, T
    VIZETHUM, W
    JACOBS, A
    BOLSEN, K
    GOERZ, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 74 (06) : 459 - 459
  • [36] INDUCTION OF DRUG-METABOLIZING-ENZYMES BY XENOBIOTICS
    BOCK, KW
    LIPP, HP
    BOCKHENNIG, BS
    XENOBIOTICA, 1990, 20 (11) : 1101 - 1111
  • [37] MOLYBDENUM HYDROXYLASES AS DRUG-METABOLIZING-ENZYMES
    BEEDHAM, C
    DRUG METABOLISM REVIEWS, 1985, 16 (1-2) : 119 - 156
  • [38] INDUCTION OF DRUG-METABOLIZING-ENZYMES BY SULFINPYRAZONE
    WALTER, E
    STAIGER, C
    DEVRIES, J
    ZIMMERMANN, R
    WEBER, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (05) : 353 - 358
  • [39] THE EFFECTS OF HYPOXIA ON DRUG-METABOLIZING-ENZYMES
    WOODROOFFE, AJM
    BAYLISS, MK
    PARK, GR
    DRUG METABOLISM REVIEWS, 1995, 27 (03) : 471 - 495
  • [40] EFFECT OF POLYASPARTAMIDES ON DRUG-METABOLIZING-ENZYMES
    DROBNIK, J
    KALAL, J
    DABROWSKA, L
    PRAUS, R
    VACHOVA, M
    ELIS, J
    JOURNAL OF POLYMER SCIENCE PART C-POLYMER SYMPOSIUM, 1979, (66): : 75 - 81